Intech Investment Management LLC Sells 5,465 Shares of Core Laboratories Inc. $CLB

Intech Investment Management LLC decreased its holdings in Core Laboratories Inc. (NYSE:CLBFree Report) by 11.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 41,703 shares of the oil and gas company’s stock after selling 5,465 shares during the period. Intech Investment Management LLC’s holdings in Core Laboratories were worth $480,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Assetmark Inc. lifted its stake in shares of Core Laboratories by 92.5% in the 1st quarter. Assetmark Inc. now owns 2,887 shares of the oil and gas company’s stock valued at $43,000 after purchasing an additional 1,387 shares during the last quarter. Mackenzie Financial Corp raised its holdings in Core Laboratories by 5.0% during the 1st quarter. Mackenzie Financial Corp now owns 24,556 shares of the oil and gas company’s stock valued at $368,000 after buying an additional 1,170 shares during the period. XTX Topco Ltd bought a new stake in Core Laboratories in the first quarter worth $155,000. Natixis Advisors LLC purchased a new position in Core Laboratories during the first quarter worth $257,000. Finally, Raiffeisen Bank International AG boosted its stake in Core Laboratories by 5.0% during the first quarter. Raiffeisen Bank International AG now owns 104,977 shares of the oil and gas company’s stock worth $1,609,000 after buying an additional 5,014 shares during the period. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Core Laboratories Stock Up 1.0%

NYSE:CLB opened at $15.10 on Friday. Core Laboratories Inc. has a twelve month low of $9.72 and a twelve month high of $21.20. The company has a market cap of $703.06 million, a price-to-earnings ratio of 22.54, a price-to-earnings-growth ratio of 13.65 and a beta of 1.40. The stock has a fifty day simple moving average of $13.89 and a 200-day simple moving average of $12.42. The company has a current ratio of 2.37, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41.

Core Laboratories (NYSE:CLBGet Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The oil and gas company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.19 by $0.03. Core Laboratories had a net margin of 6.21% and a return on equity of 12.85%. The company had revenue of $134.52 million for the quarter, compared to the consensus estimate of $130.92 million. During the same quarter last year, the firm posted $0.25 EPS. The firm’s revenue was up .1% compared to the same quarter last year. Core Laboratories has set its Q4 2025 guidance at 0.180-0.22 EPS. Analysts anticipate that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, November 24th. Stockholders of record on Monday, November 3rd were given a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, November 3rd. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. Core Laboratories’s dividend payout ratio (DPR) is 5.97%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Core Laboratories in a report on Monday. Zacks Research raised shares of Core Laboratories from a “strong sell” rating to a “hold” rating in a research report on Friday, August 15th. Four investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Core Laboratories has a consensus rating of “Hold” and a consensus target price of $12.50.

Read Our Latest Report on CLB

Core Laboratories Company Profile

(Free Report)

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

Further Reading

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories Inc. (NYSE:CLBFree Report).

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.